Follow
Jingyu Xiang
Jingyu Xiang
Verified email at wustl.edu
Title
Cited by
Cited by
Year
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling
X Su, DH Floyd, A Hughes, J Xiang, JG Schneider, O Uluckan, E Heller, ...
The Journal of clinical investigation 122 (10), 3579-3592, 2012
1022012
Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment
E Heller, MA Hurchla, J Xiang, X Su, S Chen, J Schneider, KS Joeng, ...
Cancer research 72 (4), 897-907, 2012
872012
Antagonizing integrin β3 increases immunosuppression in cancer
X Su, AK Esser, SR Amend, J Xiang, Y Xu, MH Ross, GC Fox, ...
Cancer research 76 (12), 3484-3495, 2016
742016
CXCR4 protein epitope mimetic antagonist POL5551 disrupts metastasis and enhances chemotherapy effect in triple-negative breast cancer
J Xiang, MA Hurchla, F Fontana, X Su, SR Amend, AK Esser, GJ Douglas, ...
Molecular cancer therapeutics 14 (11), 2473-2485, 2015
622015
JARID2 functions as a tumor suppressor in myeloid neoplasms by repressing self-renewal in hematopoietic progenitor cells
H Celik, WK Koh, AC Kramer, EL Ostrander, C Mallaney, DAC Fisher, ...
Cancer cell 34 (5), 741-756. e8, 2018
562018
Breast cancer–derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment
X Su, Y Xu, GC Fox, J Xiang, KA Kwakwa, JL Davis, JI Belle, WC Lee, ...
The Journal of clinical investigation 131 (20), 2021
532021
Noncompetitive Modulation of the Proteasome by Imidazoline Scaffolds Overcomes Bortezomib Resistance and Delays MM Tumor Growth in Vivo
TA Lansdell, MA Hurchla, J Xiang, S Hovde, KN Weilbaecher, RW Henry, ...
ACS chemical biology 8 (3), 578-587, 2013
422013
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer
AK Esser, MH Ross, F Fontana, X Su, A Gabay, GC Fox, Y Xu, J Xiang, ...
Theranostics 10 (17), 7510, 2020
282020
HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice
AK Esser, DA Rauch, J Xiang, JC Harding, NA Kohart, MH Ross, X Su, ...
Oncotarget 8 (41), 69250, 2017
212017
Heparanase blockade as a novel dual-targeting therapy for COVID-19
J Xiang, M Lu, M Shi, X Cheng, KA Kwakwa, JL Davis, X Su, SJ Bakewell, ...
Journal of virology 96 (7), e00057-22, 2022
182022
Targeted therapy to β3 integrin reduces chemoresistance in breast cancer bone metastases
GC Fox, X Su, JL Davis, Y Xu, KA Kwakwa, MH Ross, F Fontana, J Xiang, ...
Molecular cancer therapeutics 20 (6), 1183-1198, 2021
182021
HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia
J Xiang, DA Rauch, DD Huey, AR Panfil, X Cheng, AK Esser, X Su, ...
JCI insight 4 (19), 2019
152019
Evaluating acetate metabolism for imaging and targeting in multiple myeloma
F Fontana, X Ge, X Su, D Hathi, J Xiang, S Cenci, R Civitelli, KI Shoghi, ...
Clinical Cancer Research 23 (2), 416-429, 2017
142017
Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model
AK Esser, AH Schmieder, MH Ross, J Xiang, X Su, G Cui, H Zhang, ...
Nanomedicine: Nanotechnology, Biology and Medicine 12 (1), 201-211, 2016
142016
Machine learning–based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors
J Xiang, M Shi, MA Fiala, F Gao, MP Rettig, GL Uy, MA Schroeder, ...
Blood Advances 6 (7), 1991-2000, 2022
112022
Mouse model recapitulates the phenotypic heterogeneity of human adult T-cell leukemia/lymphoma in bone
NA Kohart, SM Elshafae, W Supsahvad, A Alasonyalilar-Demirer, ...
Journal of Bone Oncology 19, 100257, 2019
102019
An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies
J Xiang, JM Devenport, AJ Carter, KW Staser, MY Kim, J O’Neal, ...
Leukemia 37 (12), 2448-2456, 2023
92023
Parathyroid hormone-related protein promotes bone loss in T-cell leukemia as well as in solid tumors
NA Kohart, SM Elshafae, AA Demirer, WP Dirksen, JT Breitbach, ST Shu, ...
Leukemia & lymphoma 61 (2), 409-419, 2020
42020
Despite Use of Upfront Plerixafor and G-CSF, Daratumumab Exposure Reduces Stem Cell Mobilization in Patients with Multiple Myeloma
J Edmisson, MA Fiala, MJ Slade, A Vickroy, M Kavanaugh, C Wilson, ...
Blood 140 (Supplement 1), 4295-4296, 2022
32022
An “Off-the-shelf” CD2 universal CAR-T therapy combined with a long-acting IL-7 for T-cell Malignancies
J Xiang, J Devenport, AJ Carter, K Staser, MP Rettig, MY Kim, J O'Neal, ...
Blood 142, 764, 2023
22023
The system can't perform the operation now. Try again later.
Articles 1–20